(VIANEWS) – ELIS (ELIS.PA), MEDISTIM (MEDI.OL), ASML HOLDING (ASML.AS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. ELIS (ELIS.PA)
77.2% sales growth and 6.57% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €0.85.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 20.4. Meaning, the purchaser of the share is investing €20.4 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.57%.
Sales Growth
ELIS’s sales growth for the next quarter is 77.2%.
More news about ELIS.
2. MEDISTIM (MEDI.OL)
16.7% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.62.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 43.5. Meaning, the purchaser of the share is investing kr43.5 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
Sales Growth
MEDISTIM’s sales growth is 15.7% for the current quarter and 16.7% for the next.
Yearly Top and Bottom Value
MEDISTIM’s stock is valued at kr288.00 at 07:20 EST, way below its 52-week high of kr330.00 and way above its 52-week low of kr184.80.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 17.7% and positive 11.1% for the next.
Volume
Today’s last reported volume for MEDISTIM is 66 which is 99.41% below its average volume of 11230.
More news about MEDISTIM.
3. ASML HOLDING (ASML.AS)
11.1% sales growth and 74.04% return on equity
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Earnings Per Share
As for profitability, ASML HOLDING has a trailing twelve months EPS of €17.62.
PE Ratio
ASML HOLDING has a trailing twelve months price to earnings ratio of 33.87. Meaning, the purchaser of the share is investing €33.87 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 74.04%.
Sales Growth
ASML HOLDING’s sales growth is 23.2% for the present quarter and 11.1% for the next.
More news about ASML HOLDING.
4. MELEXIS (MELE.BR)
10.3% sales growth and 41.13% return on equity
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN transceiver, CAN transceiver, RFID Transceiver NFC Sensor tag ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.
Earnings Per Share
As for profitability, MELEXIS has a trailing twelve months EPS of €4.94.
PE Ratio
MELEXIS has a trailing twelve months price to earnings ratio of 16.86. Meaning, the purchaser of the share is investing €16.86 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.13%.
Moving Average
MELEXIS’s worth is way below its 50-day moving average of €97.55 and below its 200-day moving average of €86.50.
More news about MELEXIS.
5. SPBK 1 NORDMØRE (SNOR.OL)
7.1% sales growth and 9.57% return on equity
SpareBank 1 Nordmøre provides various banking services in Norway. The company offers savings and deposit accounts; car, motorcycle, boat, and construction loans; and mortgages. It also provides business insurance products, which include liability, auto, mortgage, operating loss, asset, commercial, and project insurance products; personal insurance products, such as life, travel, and accidental insurance products; pension products; bank cards; payment and debt collection services; and mobile and online banking services. In addition, the company offers bank guarantees, trade credit products, and operating credit products for agriculture, as well as factoring, leasing, and repayment products and services. The company was founded in 1835 and is based in Kristiansund, Norway. SpareBank 1 Nordmøre is a subsidiary of SpareBank 1 Gruppen AS.
Earnings Per Share
As for profitability, SPBK 1 NORDMØRE has a trailing twelve months EPS of kr13.68.
PE Ratio
SPBK 1 NORDMØRE has a trailing twelve months price to earnings ratio of 8.85. Meaning, the purchaser of the share is investing kr8.85 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.57%.
Volume
Today’s last reported volume for SPBK 1 NORDMØRE is 291 which is 74.49% below its average volume of 1141.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 15.2% and 87.6%, respectively.
Moving Average
SPBK 1 NORDMØRE’s worth is below its 50-day moving average of kr126.34 and under its 200-day moving average of kr126.03.
Sales Growth
SPBK 1 NORDMØRE’s sales growth is 38.5% for the ongoing quarter and 7.1% for the next.
More news about SPBK 1 NORDMØRE.
6. SPAREBANKEN VEST (SVEG.OL)
5.4% sales growth and 13.51% return on equity
Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. The company operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. It is also involved in home mortgage activities. The company was founded in 1823 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr10.66.
PE Ratio
SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 8.89. Meaning, the purchaser of the share is investing kr8.89 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.51%.
Sales Growth
SPAREBANKEN VEST’s sales growth is 32.9% for the current quarter and 5.4% for the next.
More news about SPAREBANKEN VEST.
